Patents by Inventor Serge Lamothe

Serge Lamothe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AMINO ACID DERIVATIVES FOR THE TREATMENT OF NEUROPATHIC PAIN
    Publication number: 20140171507
    Abstract: The invention relates to compounds, to compositions comprising the same and uses thereof for the prevention or treatment of pain, e.g neuropathic pain while having neutral or beneficial effect on metabolic parameters.
    Type: Application
    Filed: September 6, 2013
    Publication date: June 19, 2014
    Inventors: Xianqi KONG, Nigel LEVENS, Serge LAMOTHE, Mohammed ATFANI, Stephane CIBLAT, Lucie JETTE
  • AMINO ACID DERIVATIVES FOR THE TREATMENT OF NEUROPATHIC PAIN
    Publication number: 20120208876
    Abstract: The invention relates to compounds, to compositions comprising the same and uses thereof for the prevention or treatment of pain, e.g neuropathic pain while having neutral or beneficial effect on metabolic parameters.
    Type: Application
    Filed: November 4, 2011
    Publication date: August 16, 2012
    Inventors: Xianqi KONG, Nigel LEVENS, Serge LAMOTHE, Mohamed ATFANI, Stephane CIBLAT, Lucie JETTE
  • ORGANIC NUTRIENT SALTS, METHODS OF PREPARATION AND USES
    Publication number: 20110313040
    Abstract: The invention relates to organic nutrient salts, to compositions containing the same, to their preparation as well as their use. Preferred compositions include nutraceutical compositions and dietary supplements for use in neuroprotection and for improving or protecting cognitive and memory function.
    Type: Application
    Filed: November 13, 2009
    Publication date: December 22, 2011
    Applicant: BELLUS HEALTH INC.
    Inventors: Xianqi Kong, Nigel Levens, Serge Lamothe, Ahmed Aman
  • Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer
    Patent number: 6960594
    Abstract: A novel compound which inhibits certain integrins, particularly ?v integrins. Additionally, the novel compound may be used in a method of treating tumors or cancer which comprises administering a pharmaceutically effective amount of the compound to a patient. Additionally, the novel compound may be used in a method of inhibiting angiogensis. Finally, a method of producing the novel compound is disclosed.
    Type: Grant
    Filed: January 16, 2002
    Date of Patent: November 1, 2005
    Assignee: Shire BioChem Inc.
    Inventors: Denis Labrecque, Serge Lamothe, Marc Courchesne, Laval Chan, Giorgio Attardo, Karen Meerovitch
  • Quinolizinones as integrin inhibitors
    Patent number: 6630488
    Abstract: The present invention is directed towards novel compounds that are effective inhibitors of integrins, particularly &agr;IIb&bgr;3 or &agr;v integrins such as &agr;v&bgr;3 and &agr;v&bgr;5. One embodiment of the present invention comprises a compound of formula (I) or formula (II) or a pharmaceutically acceptable salt, solvate, or metabolic precursor thereof. R1, R2, R3, and R4 are defined herein.
    Type: Grant
    Filed: March 20, 2001
    Date of Patent: October 7, 2003
    Assignee: Biochem Pharma, Inc.
    Inventors: Serge Lamothe, Boulos Zacharie, Giorgio Attardo, Denis Labrecque, Marc Courchesne, Guy Falardeau, Rabindra Rej, Shaun Abbott
  • N3-substituted 6-anilinopyrimidines and methods to treat-Gram-positive bacterial and mycoplasmal infections
    Publication number: 20030114445
    Abstract: Compounds useful for treating Gram-positive bacterial and mycoplasmal infections are disclosed. The compounds have the general formulae shown below.
    Type: Application
    Filed: June 17, 2002
    Publication date: June 19, 2003
    Inventors: Chengxin Zhi, Zheng-Yu Long, George E. Wright, Neal C. Brown, Serge Lamothe, Irina Motorina
  • Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer
    Publication number: 20020137947
    Abstract: A novel compound which inhibits certain integrins, particularly &agr;v integrins. Additionally, the novel compound may be used in a method of treating tumors or cancer which comprises administering a pharmaceutically effective amount of the compound to a patient. Additionally, the novel compound may be used in a method of inhibiting angiogensis. Finally, a method of producing the novel compound is disclosed.
    Type: Application
    Filed: January 16, 2002
    Publication date: September 26, 2002
    Applicant: BioChem Pharma Inc.
    Inventors: Denis Labrecque, Serge Lamothe, Marc Courchesne, Laval Chan, Giorgio Attardo, Karen Meerovitch
  • Thiophene integrin inhibitors
    Patent number: 6274620
    Abstract: The present invention comprises compounds that are effective inhibitors of integrins, particularly &agr;v&bgr;3 and &agr;v&bgr;5 integrins. Particularly, the compounds are of formula I and pharmaceutically acceptable salts thereof wherein X,Y1 W, R1 to R5, A and B are defined according to the disclosure herein.
    Type: Grant
    Filed: June 7, 2000
    Date of Patent: August 14, 2001
    Assignee: BioChem Pharma Inc.
    Inventors: Denis Labrecque, Giorgio Attardo, Monica Bubenik, Laval Chan, Sylvie Charron, Réal Denis, Guy Falardeau, Serge Lamothe, Patrice Préville, Boulos Zacharie
  • Antineoplastic heteronapthoquinones
    Patent number: 5736523
    Abstract: This invention relates to a naphthoquinone derivatives, to processes and to intermediates for preparing these derivatives, to pharmaceutical composition and to the use of these derivatives as antitumor agents in mammals.
    Type: Grant
    Filed: March 10, 1995
    Date of Patent: April 7, 1998
    Assignee: Biochem Pharma Inc.
    Inventors: Giorgio Attardo, Tibor Breining, Marc Courchesne, Serge Lamothe, Jean-Fran.cedilla.ois Lavallee, Dieu Nguyen, Rabindra Rej, Yves St-Denis, Wuyi Wang, Yao-Chang Xu, France Barbeau, Elaine Lebeau, Jean Louis Kraus
  • Processes antineoplastic heteronaphthoquinones
    Patent number: 5606037
    Abstract: This invention relates to a naphthoquinone derivatives, to processes and to intermediates for preparing these derivatives, to pharmaceutical composition and to the use of these derivatives as antitumor agents in mammals.
    Type: Grant
    Filed: March 10, 1995
    Date of Patent: February 25, 1997
    Assignee: BioChem Pharma Inc.
    Inventors: Giorgio Attardo, Tibor Breining, Marc Courchesne, Serge Lamothe, Jean-Fran.cedilla.ois Lavall ee, Dieu Nguyen, Rabindra Rej, Yves St-Denis, Wuyi Wang, Yao-Chang Xu, France Barbeau, Elaine Lebeau, Jean L. Kraus